Table 2. The association between MCC and clinicopathologic characteristics.
| Variable | n | MCCinvasive |
P | MCCadjacent |
P | ||
|---|---|---|---|---|---|---|---|
| ≤4 | >4 | ≤8 | >8 | ||||
| Age(year) | 0.093 | 0.389 | |||||
| ≤59 | 80 | 46 | 34 | 35 | 45 | ||
| >59 | 75 | 33 | 42 | 38 | 37 | ||
| Gender | 0.153 | 0.484 | |||||
| Male | 91 | 42 | 49 | 45 | 46 | ||
| Female | 64 | 37 | 27 | 28 | 36 | ||
| Location of primary tumor | 0.536 | 0.663 | |||||
| Left | 92 | 45 | 47 | 42 | 50 | ||
| Right | 63 | 34 | 29 | 31 | 32 | ||
| Pathologic classification | 0.436 | a0.029 | |||||
| Papillary + tubular | 132 | 69 | 63 | 67 | 65 | ||
| Other | 23 | 10 | 13 | 6 | 17 | ||
| Grade | 0.847 | 0.726 | |||||
| G1 | 15 | 7 | 8 | 8 | 7 | ||
| G2 | 109 | 56 | 53 | 53 | 56 | ||
| G3 | 25 | 12 | 13 | 10 | 15 | ||
| G4 | 6 | 4 | 2 | 2 | 4 | ||
| Depth of penetration | 0.396 | 0.054 | |||||
| T1 | 6 | 3 | 3 | 1 | 5 | ||
| T2 | 32 | 20 | 12 | 21 | 11 | ||
| T3 | 92 | 46 | 46 | 41 | 51 | ||
| T4 | 25 | 10 | 15 | 10 | 15 | ||
| Lymph node involvement | 0.352 | 0.089 | |||||
| N0 | 76 | 35 | 41 | 42 | 34 | ||
| N1 | 62 | 36 | 26 | 26 | 36 | ||
| N2 | 17 | 8 | 9 | 5 | 12 | ||
| Distant metastases | 0.970 | a0.008 | |||||
| M0 | 114 | 58 | 56 | 61 | 53 | ||
| M1 | 41 | 21 | 20 | 12 | 29 | ||
| Hepatic metastases | 0.997 | a0.027 | |||||
| No | 100 | 51 | 49 | 54 | 46 | ||
| Metachronous | 14 | 7 | 7 | 7 | 7 | ||
| Synchronous | 41 | 21 | 20 | 12 | 29 | ||
Chi-square tests, aP<0.05, statistically significant.